B2i Digital, Inc. has announced that Genvor Inc. (OTCQB: GNVR) has joined the B2i Digital platform as a Featured Company, a partnership aimed at expanding investor awareness of Genvor's AI-accelerated peptide platform and sustainable agricultural solutions. Based in Woodland, California, Genvor is an agricultural biotechnology innovator developing sustainable crop-protection solutions through AI-accelerated peptide design. Founded in 2018, the company is advancing a suite of antimicrobial, insecticidal, and nutrient-enhancing peptides built on its proprietary BioCypher Algorithm, which targets the estimated $220 billion in annual global crop losses caused by plant pathogens.
David Shapiro, CEO of B2i Digital, said, 'We look forward to helping Genvor reach interested investors through our multi-channel digital marketing engine and targeted outreach campaigns. I have been particularly impressed with Genvor’s leadership and their ability to clearly articulate the growing demand for biological solutions in agriculture - and how their platform is designed to meet that need.' Genvor’s BioCypher Algorithm leverages more than 50,000 designed peptides and over 30 years of foundational research to produce targeted solutions for major agricultural challenges. The platform has demonstrated broad-spectrum efficacy, including 76%–98% reductions in total aflatoxin contamination in transgenic corn seeds across pathogens such as Aspergillus flavus and Fusarium species.
Chad Pawlak, CEO of Genvor, stated, 'As we continue our accelerated momentum with recently issued patents, active partnership discussions, and a growing pipeline, this is a key moment to expand investor engagement. We look forward to leveraging B2i Digital’s platform to connect with investors who understand the growing demand for sustainable crop protection and the value of our licensing-first business model.' Genvor maintains a growing intellectual property portfolio, including two issued U.S. patents and one pending application covering 24 proprietary peptides. In November 2025, the company announced the issuance of U.S. Patent No. 12,458,684 for transgenic corn expressing antifungal peptide AGM182, co-assigned to Genvor Inc. and the United States Department of Agriculture (USDA). This patent represents a significant milestone in validating the commercial potential of Genvor’s seed-trait technologies for major row crops.
Genvor’s development pipeline spans multiple crops - including corn, citrus, rice, soybeans, cotton, flax, and potato - with applications across both foliar spray solutions and seed traits. The company is currently engaged with major agricultural companies on joint venture evaluations and commercialization discussions. The partnership with B2i Digital is expected to enhance Genvor's visibility among potential investors and partners, leveraging B2i Digital's proprietary network of more than 1.4 million market participants. B2i Digital, founded in 2021 by former Maxim Group Investment Banker and Chief Marketing Officer David Shapiro, blends digital marketing technology with capital markets expertise to deliver executive-level investor engagement and institutional-quality exposure for growth companies.
For more information about Genvor, visit www.genvor.com. For more information about B2i Digital, visit https://b2idigital.com. The original release can be viewed on www.newmediawire.com.
